Strategic Transformation and Growth Prospects: Mayank Mamtani’s Buy Rating on Novavax
B.Riley Financial analyst Mayank Mamtani has maintained their bullish stance on NVAX stock, giving a Buy rating on November 13.Don't Miss our ...
Zacks.com on MSN15h
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
Reuters6d
Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales
Nov 12 (Reuters) - Novavax (NVAX.O), opens new tab cut its annual revenue forecast on Tuesday, citing lower-than-expected ...
Novavax, Inc. (NVAX) Q3 2024 Earnings Call Transcript
Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...
HC Wainwright Estimates Novavax’s Q3 Earnings (NASDAQ:NVAX)
Stock analysts at HC Wainwright issued their Q3 2024 earnings estimates for shares of Novavax in a note issued to investors ...
Hosted on MSN5d
Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript
Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good morning and welcome to Novavax' ...
Novavax Stock is Slipping After the Vaccine Maker Cut its Outlook Again
Novavax shares dropped Tuesday morning after the company slashed its full-year outlook when it announced its third-quarter ...
Novavax: Balancing Potential and Risk Amid Strategic Shifts and Uncertain Market Outlook
Analyst Alec Stranahan of Bank of America Securities reiterated a Hold rating on Novavax (NVAX – Research Report), reducing the price ...
Yahoo Finance3d
Novavax, Inc. (NASDAQ:NVAX) Just Reported Earnings, And Analysts Cut Their Target Price
Novavax, Inc. (NASDAQ:NVAX) investors will be delighted, with the company turning in some strong numbers with its latest results. Revenues were better than expected, with US$85m in revenue some 15 ...